secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-07-27T21:05:36+00:00
Accession:  0001493152-26-034837
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics removes $10M cap on ATM equity offering with Maxim Group
-----------------------------------------------------------------------

- Amendment to equity distribution agreement removes fixed $10M aggregate limit on common stock sales.
- Future sales limited only by registered shares available under effective S-3 registration statement.
- Company extends standstill period with prior investors to August 14, 2026, restricting further equity issuances.
- Sales will be made through Maxim Group as agent under new prospectus supplement filed July 27, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/0001493152-26-034837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer